Previous Page  10 / 32 Next Page
Information
Show Menu
Previous Page 10 / 32 Next Page
Page Background

Page 41

conferenceseries

.com

Volume 4

Toxicology: Open Access

ISSN: 2476-2067

Toxicology Congress 2018

March 12-14, 2018

March 12-14, 2018 Singapore

14

th

World Congress on

Toxicology and Pharmacology

Brain free hemoglobin increase is different among anticoagulant classes

Sergey V Brodsky

The Ohio State University, USA

Background & Aim:

Anticoagulant therapy is broadly used to prevent thromboembolic events. Intracranial hemorrhages

are serious complications of anticoagulation, especially with vitamin K inhibitors, including warfarin. Novel direct oral

anticoagulants (DOAC) reduce, but not completely eliminate the risk of intracranial hemorrhages. The aim of this study was

to investigate the severity of brain hemorrhages as measured by free hemoglobin in the brain parenchyma, among different

anticoagulant classes in rats.

Methods:

Rats were treated with excessive doses (LD50) of different anticoagulant classes (vitamin K antagonists, including

brodifacoum and warfarin, heparin, direct thrombin inhibitor and factor Xa inhibitor). Free hemoglobin concentration was

measured in the brain.

Results:

Vitamin K antagonists resulted in significant increase in free hemoglobin in the brain. Among DOAC, direct thrombin

inhibitor dabigatran also increased free hemoglobin in the brain, whereas treatment with factor Xa inhibitor rivaroxaban did

not have effect on free hemoglobin concentration.

Conclusion:

Our data indicate that different anticoagulant class result in different accumulation of free hemoglobin in the

brain and it is more pronounced with vitamin K inhibitors.

Biography

Sergey V Brodsky is an Associate Professor of Department of Pathology, The Ohio State University Wexner Medical Center (OSUWMC), Columbus, OH. He has

published more than 25 papers in reputed journals and has been serving as an Editorial Board Member of

American Journal of Physiology, American Journal of

Transplantation, ISRN Transplantation and Pharmacological Research

.

sergey.brodsky@osumc.edu

Sergey V Brodsky, Toxicol Open Access 2018, Volume 4

DOI: 10.4172/2476-2067-C1-005